Longboard Pharmaceuticals (LBPH)
(Delayed Data from NSDQ)
$59.40 USD
+0.32 (0.54%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $59.39 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 36% (91 out of 250)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.89 | 1.37 | 9.99 |
Current Quarter Estimate | -0.59 | 2.59 | 63.00 |
Year Ago Quarter Estimate | -0.55 | -4.98 | 52.25 |
Next Quarter Estimate | -0.63 | 3.37 | 66.00 |
Next Year Estimate | -2.80 | 23.17 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8.37 | 17.40 | 15.67 |
Next Year | -27.85 | 10.00 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.28 |
Price/Book (MRQ) | 7.80 | 1.95 |
Price/Cash Flow (MRFY) | NA | 14.78 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -101.26% |
Return on Equity (TTM) | -36.93% | -66.38% |
Debt to Equity (MRQ) | NA | 40.92 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.